04.02.2014 18:06:32

Press Release: Actelion to discuss full year 2013 financial results

-1 of 2- 04 Feb 2014 16:35:00 UTC  *DJ Actelion to discuss full year 2013 financial results

   (MORE TO FOLLOW) Dow Jones Newswires

   February 04, 2014 11:35 ET (16:35 GMT)- - 11 35 AM EST 02-04-14

-2 of 2- 04 Feb 2014 16:35:00 UTC  Press Release: Actelion to discuss full year 2013 financial results

Actelion Pharmaceuticals Ltd / Actelion to discuss full year 2013 financial results . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Dear member of the investment community

Actelion Ltd will announce its 2013 full year financial results on Tuesday, 11 February 2014, at 07.00 hrs CET / 06.00 hrs GMT / 01.00 a.m. EDT. An investor conference call & webcast will be held at 14.00 hrs, CET.

Date/Time:

11 February 2014 14.00 hrs - 14.45 Basel (CET) hrs 13.00 hrs - 13.45 UK (GMT) hrs 08.00 a.m. - US (EST) 08.45 a.m.

Conference Call Connect #:

Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.

Dial: Europe: +41 (0)44 580 00 69 UK: +44 (0) 203 367 94 61 US: +1 866 907 59 25

Participant's mode:

Listen-Only with possibility to open individual lines during Q&A session.

Participants will be asked for their Name and Company.

Webcast Access:

Webcast participants should visit the Actelion website http://www.actelion.com 10-15 minutes before the conference is due to start.

Participant's mode:

Listen-Only

Webcast Replay:

The archived Investor Webcast will be available for replay through http://www.actelion.com/ approximately 60 minutes after the call has ended.

Invitation PDF: http://hugin.info/131801/R/1759049/594775.pdf

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Actelion Pharmaceuticals Ltd via Globenewswire

HUG#1759049

--- End of Message ---

Actelion Pharmaceuticals Ltd

Gewerbestrasse 16 Allschwil Switzerland

ISIN: CH0010532478;

http://www.actelion.com (END) Dow Jones Newswires

   February 04, 2014 11:35 ET (16:35 GMT)- - 11 35 AM EST 02-04-14

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Actelion Ltd.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Actelion Ltd.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 681,75 0,25%